Not checkedNot checked for notices yet.
The cyclooxygenase-1/mPGES-1/endothelial prostaglandin EP4 receptor pathway constrains myocardial ischemia-reperfusion injury
Liyuan Zhu, Chuansheng Xu, Xingyu Huo and 10 more
Nature Communications · 2019
doi:10.1038/s41467-019-09492-4 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
The use of nonsteroidal anti-inflammatory drugs inhibiting COX-1/2 is associated with an increased risk of heart failure. Here the authors show that mPGES-1, a therapeutic target downstream of COX enzymes, protects from cardiac ischemia/reperfusion injury, limiting leukocyte-endothelial interactions and preserving microvascular perfusion partly via the endothelial EP4 receptor.
Abstract licence: CC BY-NC-ND
References51
40 more references, whose wording the paper’s licence keeps private.
All 51 referencesCited by papers we hold1
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.